Desktop Site
|
19 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,088.33
+599.34
+0.83 %
Corporate Announcement
Security Code
533573
Company
Alembic Pharmaceuticals Ltd
Exchange Received Time
24/10/2019 09:34:41
Exchange Disseminated Time
24/10/2019 09:34:49
Time Taken
00:00:08
Announcement under Regulation 30 (LODR)-Press Release / Media Release |
10/24/2019 9:34:43 AM
With reference to the captioned subject, this is to inform the exchange that the Company's joint venture, Aleor Dermaceuticals Limited, has received US Food and Drug Administration (USFDA) Approval for Desonide Ointment, 0.05%.
Please find enclosed herewith our press release.
We request you to kindly take the same on record.
Attachment
<< Back
Recently Viewed